Riffault B, Kourdougli N, Dumon C, Ferrand N, Buhler E, Schaller F, et al
Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats
B., Lee, H
The FDA classified Epitalon as a Category 2 bulk drug substance under Section 503A guidance in September 2023, confirmed in September 2024
For the wider research view, see the Cagrilintide guide on how it works, study results, side effects, and legal status
That means that the molecules are designed to combine with body fluids and absorb through the mucous membranes of the body (mouth and digestive tract), instead of relying on absorption through the gut (which is no good)